556
R. A. Bunce, T. Nago, N. Sonobe and L. M. Slaughter
Vol 45
Anal. Calcd. for C10H11NO3: C, 62.17; H, 5.70; N, 7.25. Found:
C, 62.18; H, 5.70; N, 7.27.
This procedure also yielded N-[4-(2-fluoro-5-nitrophenyl)-
butyl]benzylamine (25) as a minor product. However, using the
above procedure at 45° for 2 hours, 25 was produced as the
major product (89 mg, 80%). ir: 3325, 1525, 1350, 1241 cm-1;
1H nmr: δ 8.11 (m, 1H), 8.07 (m, 1H), 7.36-7.20 (complex, 5H),
7.13 (t, 1H, J = 9.0), 3.78 (s, 2H), 2.72 (t, 2H, J = 7.1), 2.67 (t,
2H, J = 7.1), 1.70 (m, 2H), 1.58 (m, 2H), 1.36 (br s, 1H); 13C
nmr: δ 164.6 (d, J = 256.2), 144.2, 140.3, 131.0 (d, J = 18.6),
128.3, 128.0, 126.9, 126.3 (d, J = 7.4), 123.5 (d, J = 10.3), 116.0
(d, J = 25.5), 54.0, 48.9, 29.6, 28.7 (d, J = 2.0), 27.3. Anal.
Calcd. for C17H19FN2O2: C, 67.55; H, 6.29; N, 9.27. Found: C,
67.59; H, 6.31; N, 9.22.
Attempted Synthesis of 1-Benzyl-5-nitroindoline (20).
Using the procedure for the preparation of 16, 100 mg (0.40
mmoles) of 13 was treated dropwise with benzylamine at 0° and
the reaction was slowly allowed to warm to room temperature
(24 hours). Workup gave a dark yellow oil that was purified by
preparative thin layer chromatography using 5-20% ether in
hexanes to give four bands: band 1, 2-fluoro-5-nitrostyrene
(21); band 2, recovered 13 (18 mg, 18%); band 3, a mixture of
20 and 2-(N-benzylamino)-5-nitrostyrene (22). The compounds
in band 3 were treated with excess acetic anhydride and pyridine
at 85° for 12 hours to acylate the aniline then separated by
preparative thin layer chromatography to give 2 bands: band 1,
20; band 2, N-benzyl-N-(2-ethenyl-4-nitrophenyl)acetamide
(23). The physical and spectral data for 20, 21 and 23 are given
below. Yields are based on 82% conversion of the starting
material.
Acknowledgment. T. N. thanks the Oklahoma State
University College of Arts and Sciences for a Wentz Project
Scholarship and the Department of Chemistry for a Skinner
Scholarship; N. S. thanks the Department of Chemistry for a
Moore Scholarship. Funding for the 300 and 400 MHz NMR
spectrometers of the Oklahoma Statewide Shared NMR Facility
was provided by the NSF (BIR-9512269), the Oklahoma State
Regents for Higher Education, the W. M. Keck Foundation, and
Conoco, Inc. Finally, the authors wish to thank the OSU College
of Arts and Sciences for funds to upgrade our departmental FT-
IR and GC-MS instruments.
1-Benzyl-5-nitroindoline (20). This compound (26 mg,
31%) was isolated as a yellow solid, mp 67-68° [17]. ir: 1608,
1
1518, 1490, 1320 cm-1; H nmr: δ 8.03 (dd, 1H, J = 8.8, 1.9),
7.90 (m, 1H), 7.40-7.23 (complex, 5H), 6.35 (d, 1H, J = 8.8),
4.43 (s, 2H), 3.63 (t, 2H, J = 8.7), 3.09 (t, 2H, J = 8.7); 13C nmr:
δ 157.0, 138.2, 136.2, 129.7, 128.8, 127.7, 127.4, 126.7, 120.8,
103.5, 52.4, 51.0, 27.0; ms: m/z 163 (M+-C7H7). Anal. Calcd.
for C15H14N2O2: C, 70.87; H, 5.51; N, 11.02. Found: C, 70.88;
H, 5.53; N, 10.98.
2-Fluoro-5-nitrostyrene (21). This compound (20 mg,
37%) was isolated as a light yellow oil. ir: 1620, 1529, 1346,
1241 cm-1; 1H nmr: δ 8.41 (dd, 1H, J = 6.3, 2.7), 8.13 (ddd, 1H, J
= 9.0, 4.4, 2.7), 7.19 (t, 1H, J = 9.0), 6.87 (dd, 1H, J = 17.7,
11.2), 5.99 (d, 1H, J = 17.7), 5.59 (d, 1H, J = 11.2); 13C nmr: δ
163.3 (d, J = 260.5), 144.4, 127.4 (d, J = 3.1), 126.6 (d, J =
17.1), 124.6 (d, J = 10.3), 122.9 (d, J = 6.0), 119.6 (d, J = 4.6),
116.8 (d, J = 24.9); ms: m/z 167 (M+). Anal. Calcd. for
C8H6FNO2: C, 57.49; H, 3.59; N, 8.38. Found: C, 57.47; H,
3.60; N, 8.34.
N- Benzyl- N- (2- ethenyl- 4- nitrophenyl) acetamide (23).
This compound (13 mg, 14%) was isolated as a colorless oil that
crystallized on standing. Trituration with 5% ether in petroleum
ether gave a light yellow solid, mp 80-82°. ir: 1669, 1610, 1525,
1346 cm-1; 1H nmr: δ 8.46 (d, 1H, J = 2.7), 8.02 (dd, 1H, J = 8.7,
2.7), 7.60-7.44 (complex, 3H), 7.38-7.25 (complex (2H), 6.94
(d, 1H, J = 8.7), 6.56 (dd, 1H, J = 17.4, 11.1), 5.93 (d, 1H, J =
17.4), 5.51 (d, 1H, J = 11.1), 5.34 (d, 1H, J = 14.0), 4.34 (d, 1H,
J = 14.0), 1.80 (s, 3H); 13C nmr: δ 169.6, 161.2, 145.0, 137.4,
136.1, 130.8, 129.8, 129.3, 128.6, 128.0, 123.2, 121.7, 120.2,
52.1, 22.6. Anal. Calcd for C17H16N2O3: C, 68.92; H, 5.41; N,
9.46. Found: C, 68.89; H, 5.44; N, 9.44.
REFERENCES AND NOTES
[1] Undergraduate research participants: T. N., 2006-present; N.
S., 2005-2006.
[2] See for example [a] Bunce, R. A.; Herron, D. M.; Ackerman,
M. L. J. Org. Chem. 2000, 65, 2847. [b] Bunce, R. A.; Herron, D. M.;
Johnson, L. B.; Kotturi, S. V. J. Org. Chem. 2001, 66, 2822. [c] Bunce,
R. A.; Randall, M. H.; Applegate, K. G. Org. Prep. Proced. Int. 2002,
34, 493. [d] Bunce, R. A.; Herron, D. M.; Lewis, J. R.; Kotturi, S. V.;
Holt, E. M. J. Heterocyclic Chem. 2003, 40, 101. [e] Bunce, R. A.;
Herron, D. M.; Hale, L. Y. J. Heterocyclic Chem. 2003, 40, 1031. [f]
Bunce, R. A.; Johnson, L. B.; Holt, E. M. J. Heterocyclic Chem. 2004,
41, 563. [g] Bunce, R. A.; Smith, C. L.; Lewis, J. R. J. Heterocyclic
Chem. 2004, 41, 963. [h] Bunce, R. A.; Schammerhorn, J. E. J.
Heterocyclic Chem. 2006, 43, 1031. [i] Bunce, R. A.; Schammerhorn, J.
E.; Slaughter, L. M. J. Heterocyclic Chem. 2006, 43, 1505.
[3] Oxygen heterocycles: [a] Chiou, W.-F.; Li, S.-Y.; Ho, L.-K.;
Hsien, M.-L.; Don, M.-J. Eur. J. Med. Chem. 2002, 37, 69. [b] Hodgetts,
K. J.; Kieltyka, A.; Brodbeck, R.; Tran, J. N.; Wasley, J. W. F.;
Thurkauf, A. Bioorg. Med. Chem. 2001, 9, 3207. [c] Hach, V; Leciva, D.
M. Coll. Czech. Chem. Commun. 1959, 24, 3136.
[4] Nitrogen heterocycles: [a] Sano, H.; Noguchi, T.; Tanatani,
A.; Hashimoto, Y.; Miyachi, H. Bioorg. Med. Chem. 2005, 13, 3079. [b]
Hanada, K.; Furuya, K.; Yamamoto, N.; Nejishima, H.; Ichikawa, K;
Nakamura, T.; Miyakawa, M.; Amano, S.; Sumita, Y.; Oguro, N. Biol.
Pharm. Bull. 2003, 26, 1563. [c] Stenkamp, D.; Mueller, S. G.; Roth, G.
J.; Lustenberger, P.; Rudolf, K.; Lehmann-Lintz, T.; Arndt, K.; Ralf, R.
H.; Lenter, M.; Wieland, H.-A. International Patent WO 2004039764,
2004; Chem. Abstr. 2004, 140, 406638. [d] Cho, I.-H.; Lim, J.-W.; Noh,
J.-Y.; Kim, J. H.; Park, S.-W.; Ryu, H.-C.; Kim, J.-H.; Chun, H.-O.;
Wang, S.-Y.; Lee, S.-H. International Patent WO 2003021409, 2003.;
Chem. Abstr. 2003, 138, 321129. [e] Reich, S. H.; Fuhry, M. A. M.
International Patent WO 9205173, 1992; Chem. Abstr. 1992, 117,
150985.
1-Benzyl- 7-nitro-2, 3, 4, 5-tetrahydro-1H- 1-benzazepine
(24). Using the procedure outlined for the preparation of 16,
100 mg (0.36 mmoles) of 14 was reacted with benzylamine at
20° for 3 hours and 120° for 12 hours to give 36 mg (35%) of 24
1
as a yellow oil. ir: 1503, 1312 cm-1; H nmr: δ 7.96 (d, 1H, J =
2.7), 7.92 (dd, 1H, J = 9.0, 2.7), 7.40-7.24 (complex, 5H), 6.75
(d, 1H, J = 9.0), 4.50 (s, 2H), 3.31 (distorted t, 2H, J = 5.5), 2.96
(distorted t, 2H, J = 5.5), 1.81 (m, 4H); 13C nmr: δ 157.0, 139.6,
137.5, 131.5, 128.7, 127.4, 127.3, 126.4, 123.4, 115.5, 57.6,
52.3, 33.7, 27.2, 24.6; ms: m/z 191 (M+-C7H7). Anal. Calcd. for
C17H18N2O2: C, 72.34; H, 6.38; N, 9.92. Found: C, 72.39; H,
6.40; N, 9.87.
[5] Carbocycles: [a] Nagata, R.; Tanno, N.; Ae, N. Canadian
Patent CA 2135811, 1995; Chem. Abstr. 1995, 124, 8615. [b] Nagata,
R.; Tanno, N.; Ae, N. European Patent EP 657427, 1995; Chem. Abstr.
1995, 123, 256515.
[6] Bunce, R. A.; Rogers, D.; Nago, T.; Bryant, S. A. J.
Heterocyclic Chem., 2008, 45, 547. This report presents another
application of the SN2-SNAr reaction.